Cargando…
Pharmacogenomic testing: perception of clinical utility, enablers and barriers to adoption in Australian hospitals
BACKGROUND: Despite healthcare professionals (HCP) endorsing the clinical utility of pharmacogenomics testing, use in clinical practice is limited. AIMS: To assess HCP' perceptions of pharmacogenomic testing and identify barriers to implementation. METHODS: HCP involved in prescribing decisions...
Autores principales: | Pearce, Angela, Terrill, Bronwyn, Alffenaar, Jan‐Willem, Patanwala, Asad E., Kummerfeld, Sarah, Day, Richard, Young, Mary‐Anne, Stocker, Sophie L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541847/ https://www.ncbi.nlm.nih.gov/pubmed/35191159 http://dx.doi.org/10.1111/imj.15719 |
Ejemplares similares
-
Discrepancies Between Bayesian Vancomycin Models Can Affect Clinical Decisions in the Critically Ill
por: Patanwala, Asad E., et al.
Publicado: (2022) -
Barriers to clinical adoption of pharmacogenomic testing in psychiatry: a critical analysis
por: Virelli, Catherine R., et al.
Publicado: (2021) -
Australian Consumer Perceptions of Regionally Grown Fruits and Vegetables: Importance, Enablers, and Barriers
por: Godrich, Stephanie, et al.
Publicado: (2019) -
The pharmacogenomic landscape of an Indigenous Australian population
por: Samarasinghe, Sumudu Rangika, et al.
Publicado: (2023) -
Adoption of Pharmacogenomic Testing: A Marketing Perspective
por: Koufaki, Margarita-Ioanna, et al.
Publicado: (2021)